TEVA - Teva Pharmaceutical ...About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
| Previous Close | $11.51 | Open | $11.76 |
| Volume | 12.78M | Market Cap | 12.434B |
| Yield | Last Dividend |
| Teva could be next DOJ target (NYSE:TEVA... | 07/02/20 |
| Teva Pharmaceuticals (NYSE:TEVA) had a rough session yesterday after the DOJ charged generic pharmaceutical giant Glenmark (OTC:GLKQY, OTCPK:GLRKF) wi... | |
| California top court says DA can seek st... | 06/25/20 |
| California's top court on Thursday ruled that county district attorneys can obtain financial recoveries in cases over statewide unfair business practi... | |
| Global Markets for Pain Management Patch... | 06/24/20 |
| DUBLIN--(BUSINESS WIRE)--The "Global Market for Pain Management Patches" report has been added to ResearchAndMarkets.com's offering. The report offers... | |
| Happy Pride! Celebrate all month long wi... | 06/23/20 |
| Filed under: Lifestyle , Shop , Trending Our team is dedicated to finding and telling you more about the products and deals we love. If you love them ... | |
| Teva Presents New Analyses Examining Cha... | 06/18/20 |
| TEL AVIV & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals USA, Inc., an affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA... | |
| Drug Stock Due for Another Climb on the ... | 06/15/20 |
| Plus, TEVA options are affordably priced at the moment | |
| Teva to Present New Data on AJOVY?? (fre... | 06/15/20 |
| TEL AVIV & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals USA, Inc., an affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA... | |
| Can These Drug Stocks Fly? It Depends on... | 06/15/20 |
| Opioid and price-fixing legal woes should lead to volatile stock moves for generic-drug makers and distributors such as Teva and McKesson. | |
| Lukewarm on Starbucks Stock | 06/12/20 |
| Also, Wall Street opinions on Teva Pharmaceutical, Bank of Hawaii, Allstate, B&G Foods, and Purple Innovation | |
| [MigVax in CTech] Israel-based medtech c... | 06/09/20 |
| Newly formed medtech startup MigVax Corp., which is working on a coronavirus (Covid-19) vaccine, has appointed Eyal Desheh as the chairman of its boar... | |
| [MigVax in Globes] Ex-Teva CFO Eyal Desh... | 06/09/20 |
| Desheh has been appointed chairman of MigVax, which is developing a vaccine based on research at the Migal Galilee Research Institute. Read more here.... | |
| Emergent (EBS) Down on Unfavorable Paten... | 06/08/20 |
| Emergent's (EBS) stock falls after a district court rules against the patent litigation on its Narcan nasal spray product. The court ruled in favor of... | |
| THE DIGITAL THERAPEUTICS EXPLAINER: How ... | 06/06/20 |
| This is a preview of The Digital Therapeutics research report from Business Insider Intelligence. Purchase this report. Business Insider Intelligence ... | |
| Teva Showcases Global Impact in 2019 Env... | 06/02/20 |
| TEL AVIV, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today published its 2019 Environmental, Social and Govern... | |
| Happy Pride! Celebrate all month long wi... | 06/01/20 |
| Filed under: Lifestyle , Shop , Trending Our team is dedicated to finding and telling you more about the products and deals we love. If you love them ... | |
| Top Analyst Upgrades and Downgrades: Ama... | 06/01/20 |
| No summary available. | |
| Teva Announces Virtual 2020 Annual Meeti... | 05/26/20 |
| TEL AVIV, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE: TEVA, TASE: TEVA) (???Teva???), announced today that, in the interest of... | |
| Can Teva (TEVA) Return to Growth in This... | 05/22/20 |
| Though Teva (TEVA) faces several challenges, with encouraging progress on restructuring activities and stabilization in the generics business, it may ... | |
| Teva to Present New AJOVY?? (fremanezuma... | 05/22/20 |
| TEL AVIV, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that new data on AJOVY?? (fremanezumab) a... | |
| Teva Celebrates Pride with New Collectio... | 05/19/20 |
| GOLETA, Calif., May 19, 2020 /PRNewswire/ -- Teva??, a division of Deckers Brands (NYSE: DECK), is excited to announce a partnership with the It Gets ... | |
| China Approves AUSTEDO?? For Treating Ch... | 05/18/20 |
| TEL AVIV, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced that the China National Medical Products... | |
| Warren Buffett's Berkshire Hathaway slas... | 05/15/20 |
| Warren Buffett's Berkshire Hathaway slashed its stake in Goldman Sachs and exited its positions in Philips 66 and Travelers in the first quarter, a fi... | |
| A Drug Company Wagers the U.S. Won???t D... | 05/15/20 |
| Teva, the world???s largest maker of generic drugs, recently pulled out of settlement talks with the Justice Department. | |
| Is Teva Pharmaceutical Industries Ltd (T... | 05/13/20 |
| Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Neverthe... | |
| Teva (TEVA) Q1 Earnings Top, Coronavirus... | 05/08/20 |
| Teva (TEVA) beats estimates for earnings and sales in first-quarter 2020. It maintains previously issued guidance for 2020. Stock up. | |
| Teva CEO Kare Schultz On Drugmaker's Out... | 05/07/20 |
| Generic drugmaker Teva Pharmaceutical Industries Ltd (NYSE: TEVA ) reported a first-quarter earnings beat as the company managed to maintain business ... | |
| Teva Pharmaceutical's profit beats forec... | 05/07/20 |
| Israel-based Teva Pharmaceutical Industries beat first-quarter profit forecasts on Thursday, boosted by stronger demand for generic and over-the-count... | |
| Teva (TEVA) Q1 Earnings & Sales Beat Est... | 05/07/20 |
| Teva beats estimates for earnings and sales in first-quarter 2020. It maintains its previously issued guidance for 2020. Stock up. | |
| Infographic: Teva Pharmaceuticals (TEVA)... | 05/07/20 |
| Teva Pharmaceuticals??? (NYSE: TEVA) first quarter 2020 results beat consensus estimates. The drugmaker reported adjusted earnings of $0.76 per share ... | |
| Teva Reports First Quarter 2020 Financia... | 05/07/20 |
| TEL AVIV, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE: TEVA, TASE: TEVA) today reported results for the quarter ended March 31,... | |
| Buy rating | 06/01/20 |
| SunTrust Robinson Humphrey upgrades from Hold to Buy rating and raises Price Target from $11.00 to $16.00 | |
| Buy rating | 05/11/20 |
| UBS maintains Buy rating and raises Price Target from $12.00 to $15.00 | |
| Underperform rating | 05/08/20 |
| and raises Price Target from $7.00 to $8.00 | |
| Buy rating | 05/08/20 |
| SVB Leerink maintains Market Perform rating and raises Price Target from $11.00 to $12.00 | |
| Hold rating | 04/15/20 |
| Piper Sandler maintains Neutral rating and lowers Price Target from $10.00 to $8.00 | |
| Date | 2020-05-07 (BMO) | Est. (EPS/Rev.) | $0.59/ 4.15B |
| Actual (EPS/Rev.) | $0.76/ $4.36 B | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Free Biotech Holdings | Scientia Equity Research | 100.00 % | Follow |
| Trading | Trading | 99.00 % | Follow |
| Swing for the fences | Gino Baldassano | 73.00 % | Subscribe |
| Arbitrage Trade Analytics | Royce Wells | 71.00 % | Subscribe |
| Alpha Swing Trades | Jonathan | 68.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
